McKesson Corporation (NYSE:MCK) : Traders are bullish on McKesson Corporation (NYSE:MCK) as it has outperformed the S&P 500 by a wide margin of 2.3% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 1.2%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 2.49% in the last 1 week, and is up 3.95% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have dropped -16.70% from its 1 Year high price. On Jul 16, 2015, the shares registered one year high at $236.86 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $183.47 and the 200 Day Moving Average price is recorded at $171.01.
The stock has recorded a 20-day Moving Average of 5.48% and the 50-Day Moving Average is 7.72%.
McKesson Corporation (NYSE:MCK): stock turned positive on Friday. Though the stock opened at $192.33, the bulls momentum made the stock top out at $193.37 level for the day. The stock recorded a low of $191.87 and closed the trading day at $192.79, in the green by 0.83%. The total traded volume for the day was 1,491,108. The stock had closed at $191.2 in the previous days trading.
In an insider trading activity, The Securities and Exchange Commission has divulged that Hammergren John H, director officer (Chairman, President & CEO) of Mckesson Corp, had unloaded 37,420 shares at an average price of $182.87 in a transaction dated on May 24, 2016. The total value of the transaction was worth $6,842,995.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.